{"id":"https://openalex.org/W4362609840","doi":"https://doi.org/10.1158/1535-7163.22505577","title":"Supplementary Figure 2 from \u03b4-Catenin Promotes Bevacizumab-Induced Glioma Invasion","display_name":"Supplementary Figure 2 from \u03b4-Catenin Promotes Bevacizumab-Induced Glioma Invasion","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362609840","doi":"https://doi.org/10.1158/1535-7163.22505577"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22505577","doi":"https://doi.org/10.1158/1535-7163.22505577","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22505577","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.22505577","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085640991","display_name":"Toshihiko Shimizu","orcid":"https://orcid.org/0000-0002-2594-234X","observed_orcids":["https://orcid.org/0000-0002-2594-234X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshihiko Shimizu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070355923","display_name":"Joji Ishida","orcid":"https://orcid.org/0000-0003-1233-2793","observed_orcids":["https://orcid.org/0000-0003-1233-2793"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joji Ishida","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1233-2793","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059538840","display_name":"Kazuhiko Kurozumi","orcid":"https://orcid.org/0000-0002-6942-9919","observed_orcids":["https://orcid.org/0000-0002-6942-9919"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kazuhiko Kurozumi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065128406","display_name":"Tomotsugu Ichikawa","orcid":"https://orcid.org/0000-0003-1946-6794","observed_orcids":["https://orcid.org/0000-0003-1946-6794"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomotsugu Ichikawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043407107","display_name":"Yoshihiro Otani","orcid":"https://orcid.org/0000-0002-1615-5125","observed_orcids":["https://orcid.org/0000-0002-1615-5125"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoshihiro Otani","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1615-5125","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Tetsuo Oka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tetsuo Oka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080681925","display_name":"Yusuke Tomita","orcid":"https://orcid.org/0000-0002-3964-823X","observed_orcids":["https://orcid.org/0000-0002-3964-823X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yusuke Tomita","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044679356","display_name":"Yasuhiko Hattori","orcid":"https://orcid.org/0000-0003-3737-3604","observed_orcids":["https://orcid.org/0000-0003-3737-3604"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yasuhiko Hattori","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035650827","display_name":"Atsuhito Uneda","orcid":"https://orcid.org/0000-0001-9709-6034","observed_orcids":["https://orcid.org/0000-0001-9709-6034"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Atsuhito Uneda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Yuji Matsumoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuji Matsumoto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5004595871","display_name":"Isao Date","orcid":"https://orcid.org/0000-0002-0218-2595","observed_orcids":["https://orcid.org/0000-0002-0218-2595"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Isao Date","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.5781000256538391,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.5781000256538391,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.40310001373291016,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/delta-catenin","display_name":"\u03b4-catenin","score":0.9079999923706055},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9660000205039978},{"id":"https://openalex.org/keywords/glioma","display_name":"glioma","score":0.8230000138282776},{"id":"https://openalex.org/keywords/tumor-invasion","display_name":"tumor invasion","score":0.9160000085830688},{"id":"https://openalex.org/keywords/wound-closure","display_name":"wound closure","score":0.8069999814033508},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.6769999861717224}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.889999508857727},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.6393370032310486},{"id":"https://openalex.org/C30145163","wikidata":"https://www.wikidata.org/wiki/Q384104","display_name":"Catenin","level":4,"score":0.49603089690208435},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4742521345615387},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.33466804027557373},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.316877543926239},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.185349702835083},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07730594277381897},{"id":"https://openalex.org/C137620995","wikidata":"https://www.wikidata.org/wiki/Q155769","display_name":"Wnt signaling pathway","level":3,"score":0.054603755474090576},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.052651941776275635},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.22505577","doi":"https://doi.org/10.1158/1535-7163.22505577","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22505577","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22505577","doi":"https://doi.org/10.1158/1535-7163.22505577","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22505577","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.8560000061988831,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7111167895","https://openalex.org/W4362542097","https://openalex.org/W2767704956","https://openalex.org/W2610123110","https://openalex.org/W7100963334","https://openalex.org/W2101180062","https://openalex.org/W7098198993","https://openalex.org/W2133598711","https://openalex.org/W2093691821","https://openalex.org/W3031196943"],"abstract_inverted_index":{"Bevacizumab":[0],"increased":[1],"the":[2],"rate":[3],"of":[4],"wound":[5],"closure":[6]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2023-04-06T00:00:00"}